Pivotal bioVenture Partners
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
6Deep-tech portfolio1 active
5Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Evommune
36Co-investorsShare a portfolio company
Portfolio · 6 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Mosanna Therapeutics | Biotech | Active | — | — |
| Evommune | Biotech | Public | Jan 8, 2025 | $267.3M |
| Kyverna Therapeutics | Biotech | Public | Nov 7, 2023 | $152.0M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
| Praxis Precision Medicine | Biotech | Public | — | — |
Peer ranks
Portfolio size#67
Portfolio exits#40
Raises, 12 months#88
Co-investors#51
Co-investors
- Broadview VenturesVenture capital2 shared
- Deerfield Capital ManagementVenture capital2 shared
- Frazier Healthcare PartnersVenture capital2 shared
- Gurnet Point CapitalVenture capital2 shared
- Omega FundsVenture capital2 shared
- Perceptive AdvisorsVenture capital2 shared
- RTW InvestmentsVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- Alloy TherapeuticsVenture capital1 shared
- Ascent Biomedical VenturesVenture capital1 shared
Sectors
- Biotech6
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.